Vivaldi Biosciences Files PCT Patent Application for Universal Flu and Covid-19 Combination Vaccine
By: Colorado BioScience Association Date: 11/30/2021
Vivaldi Biosciences, a clinical-stage biotechnology company developing nasal-spray vaccines for viral respiratory diseases, today announced it has filed an international patent application for its com...
Learn MoreSolidAIRity Flex™ Launches First-in-Patient Limited Market Release
By: Colorado BioScience Association Date: 11/22/2021
Securisyn Medical has formally launched its FDA-registered, Adult SolidAIRity Flex™ Endotracheal Tube Securement device, at Memorial Hospital - University of Colorado Health in Colorado Springs. This...
Learn MoreAspero Medical Awarded $1M Grant
By: Colorado BioScience Association Date: 11/09/2021
Startup MedTech company improving endoscopy procedures with patented balloon technology continues to develop product line Aspero Medical, a medical device startup company focused on design and develop...
Learn MoreCBSA Member SmartTab Receives Two Awards: 2021 Colorado Company to Watch and 2021 Patient's Choice Award
By: Colorado BioScience Association Date: 10/22/2021
CBSA member SmartTab is honored with two awards: SmartTab has been selected as a top award winner for the 2021 Colorado Companies to Watch. This highly prestigious award is designated to the most, “in...
Learn MorePharmaJet , WHO and BMGF conduct Somalia Polio Vaccination Campaign
By: Colorado BioScience Association Date: 10/21/2021
PharmaJet® the maker of innovative, needle-free injection technology, today announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia d...
Learn MorePharmaJet Presents Needle-free delivery of COVID-19 Vaccines and Beyond at World Vaccine Congress - Europe
By: Colorado BioScience Association Date: 10/13/2021
Superior immunogenicity expands vaccine development with Needle-free delivery PharmaJet®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and resear...
Learn MoreWeekly Policy Update: Prescription Drug Affordability Review Board Members Appointed
By: Colorado BioScience Association Date: 10/08/2021
This week, Governor Polis announced the appointment of the inaugural five members of the Prescription Drug Affordability Review Board (PDAB). The PDAB was created through the legislature’s passage and...
Learn MoreGates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta
By: Colorado BioScience Association Date: 10/07/2021
The Gates Biomanufacturing Facility (GBF) today announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells. As part of this col...
Learn MoreBrickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis Patients
By: Colorado BioScience Association Date: 10/07/2021
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for...
Learn MoreNew fund expands its investments into the Mid-America Mountain Plains region focusing on B2B SaaS, Cleantech, and Medtech Startups
By: Colorado BioScience Association Date: 10/05/2021
Innosphere Ventures announced the launch of its second venture capital fund, Innosphere Ventures Fund II (Fund II), that focuses on leading early-stage investments for companies who are driving innova...
Learn More